Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.25 trillion and total revenue of $109.81 billion.
Market Cap
1.25T
Revenue
109.81B
Profits
-41.33B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.89B | -0.82% | 1,082,002 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.75B | -1.05% | 474,280 | 14.92B |
| 3 | ARGX | argenx SE | 54.49B | -1.92% | 265,925 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.32B | 0.55% | 3,078,090 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.55B | -2.36% | 1,083,414 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 34.08B | 0.86% | 439,874 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 32.06B | -1.38% | 2,217,704 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 26.76B | 0.64% | 5,759,798 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.11B | 1.16% | 3,979,938 | 8.26M |
| 10 | INSM | Insmed Incorporated | 23.87B | 0.89% | 1,826,299 | 819.56M |
| 11 | INCY | Incyte Corporation | 22.95B | 0.57% | 1,290,610 | 5.36B |
| 12 | BNTX | BioNTech SE | 22.86B | 0.37% | 910,640 | 3.23B |
| 13 | GMAB | Genmab A/S | 17.48B | -0.24% | 1,612,816 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.49B | 0.13% | 512,538 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.48B | 1.22% | 2,699,273 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.95B | 0.46% | 739,228 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.02B | -0.48% | 1,783,039 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 1.10% | 238,748 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.11B | 3.06% | 471,898 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 12.01B | 1.11% | 3,000,267 | - |
| 21 | ABVX | ABIVAX Société Anonyme | 11.71B | -0.79% | 922,715 | 5.67M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | -0.95% | 1,380,298 | 3.24B |
| 23 | CYTK | Cytokinetics, Incorporated | 11.12B | -0.38% | 1,424,977 | 105.82M |
| 24 | TECH | Bio-Techne Corporation | 11.10B | -0.18% | 2,938,523 | 1.21B |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.13B | -2.97% | 1,621,327 | 622.01M |
| 26 | APGE | Apogee Therapeutics, Inc. | 10.04B | 0.10% | 1,288,749 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 10.01B | -6.61% | 491,365 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 9.83B | 0.02% | 3,059,070 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.71B | 5.32% | 1,149,354 | 769.10M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.22B | 1.52% | 428,373 | 51.48M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | 4.17% | 372,593 | 7.46M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.08B | -3.21% | 4,650,270 | 1.06B |
| 33 | HALO | Halozyme Therapeutics, Inc. | 8.90B | -1.39% | 1,772,386 | 1.51B |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.05% | 5,037,098 | 18.07M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 8.70B | 5.57% | 2,711,061 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 8.44B | 1.06% | 558,597 | 74.06M |
| 37 | IBRX | ImmunityBio, Inc. | 8.25B | 1.16% | 7,396,267 | 140.98M |
| 38 | PCVX | Vaxcyte, Inc. | 8.12B | -1.44% | 774,433 | - |
| 39 | IMVT | Immunovant, Inc. | 7.96B | 0.18% | 753,478 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 7.78B | -0.22% | 1,991,172 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 2.30% | 743,085 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.37B | 1.55% | 694,185 | 569.61M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.58B | 2.80% | 2,031,340 | - |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 6.51B | -0.62% | 1,035,393 | 7.50M |
| 45 | PTCT | PTC Therapeutics, Inc. | 6.48B | -4.02% | 1,601,082 | 827.11M |
| 46 | SRRK | Scholar Rock Holding Corporation | 6.44B | -1.68% | 1,074,364 | - |
| 47 | CGON | CG Oncology, Inc. | 6.33B | -1.01% | 1,103,813 | 5.07M |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.10B | 5.34% | 1,390,124 | - |
| 49 | ERAS | Erasca, Inc. | 6.06B | 8.94% | 10,608,590 | - |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.96B | -2.68% | 643,971 | 274.48M |
| 51 | BLTE | Belite Bio, Inc | 5.77B | -0.24% | 106,970 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.54B | 2.68% | 1,189,502 | 1.34M |
| 53 | CELC | Celcuity Inc. | 5.42B | 6.99% | 2,116,429 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.31B | 1.37% | 880,457 | 536.20M |
| 55 | ORKA | Oruka Therapeutics, Inc. | 5.28B | 3.44% | 892,862 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 4.97B | -0.34% | 1,700,290 | 4.10M |
| 57 | LEGN | Legend Biotech Corporation | 4.97B | -0.31% | 1,564,904 | 1.14B |
| 58 | CAI | Caris Life Sciences, Inc. | 4.79B | -0.64% | 3,589,770 | 907.29M |
| 59 | MANE | Veradermics, Incorporated | 4.60B | -0.01% | 524,868 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.41B | -0.39% | 1,310,288 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 4.36B | -0.04% | 1,203,143 | 1.10B |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.29B | 4.55% | 1,904,812 | 56.99M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -3.73% | 1,193,570 | - |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.16B | 1.87% | 1,683,249 | 10.68M |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.97B | 5.13% | 538,692 | - |
| 66 | DYN | Dyne Therapeutics, Inc. | 3.93B | 0.59% | 2,114,868 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 0.03% | 636,630 | 22.57M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 15,451,073 | 596.96M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.75B | 0.46% | 92,955 | 803.79M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.61B | 1.69% | 741,745 | - |
| 71 | GPCR | Structure Therapeutics Inc. | 3.60B | -2.03% | 533,617 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.59B | -14.46% | 5,623,548 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.56B | 0.93% | 801,993 | 236.00M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | 1.38% | 1,135,554 | 225.27M |
| 75 | ALMS | Alumis Inc. | 3.48B | -2.92% | 1,688,665 | 8.40M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | -1.14% | 763,804 | 415.62M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.15B | -3.58% | 1,068,452 | 670.00M |
| 78 | VERA | Vera Therapeutics, Inc. | 3.10B | 3.93% | 2,538,555 | - |
| 79 | BEAM | Beam Therapeutics Inc. | 3.07B | -0.35% | 1,979,803 | 164.01M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 3.00B | -0.93% | 699,434 | 865.00K |
| 81 | IRON | Disc Medicine, Inc. | 2.87B | -1.28% | 350,807 | - |
| 82 | QURE | uniQure N.V. | 2.85B | 1.02% | 967,458 | 18.09M |
| 83 | KOD | Kodiak Sciences Inc. | 2.70B | 5.26% | 880,235 | - |
| 84 | MBX | MBX Biosciences, Inc. | 2.69B | -5.75% | 1,341,076 | - |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | 6.10% | 6,004,135 | - |
| 86 | IMNM | Immunome, Inc. | 2.56B | -0.92% | 1,658,458 | 4.02M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.54B | 8.41% | 2,468,511 | - |
| 88 | KLRA | Kailera Therapeutics, Inc. | 2.46B | -4.81% | 305,044 | - |
| 89 | TARS | Tarsus Pharmaceuticals, Inc. | 2.41B | -5.40% | 2,061,420 | 535.08M |
| 90 | PHVS | Pharvaris N.V. | 2.41B | -1.85% | 279,091 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.40B | -1.12% | 555,876 | - |
| 92 | NRIX | Nurix Therapeutics, Inc. | 2.38B | 1.19% | 1,563,822 | 36.77M |
| 93 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | -1.55% | 666,265 | 66.05M |
| 94 | VCEL | Vericel Corporation | 2.35B | -2.95% | 629,974 | 292.09M |
| 95 | NKTR | Nektar Therapeutics | 2.27B | -1.68% | 800,702 | 55.63M |
| 96 | BHVN | Biohaven Ltd. | 2.25B | -1.52% | 1,433,513 | - |
| 97 | ZLAB | Zai Lab Limited | 2.17B | -1.63% | 473,516 | 453.28M |
| 98 | MESO | Mesoblast Limited | 2.16B | 3.21% | 267,109 | 65.38M |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 2.50% | 238,960 | - |
| 100 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 5.42% | 2,066,190 | 217.17M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -1.82% | 1,414,457 | 52.04M |
| 102 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 0.47% | 1,123,399 | 70.92M |
| 103 | NBTX | Nanobiotix S.A. | 2.10B | 6.36% | 73,229 | 38.27M |
| 104 | ATAI | AtaiBeckley Inc. | 2.09B | 14.08% | 11,529,077 | 3.49M |
| 105 | ABCL | AbCellera Biologics Inc. | 2.06B | 3.37% | 4,144,926 | 79.21M |
| 106 | ADMA | ADMA Biologics, Inc. | 2.06B | -1.11% | 2,677,813 | 509.86M |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -0.31% | 815,248 | 298.30M |
| 108 | NUVB | Nuvation Bio Inc. | 2.05B | 2.25% | 7,294,674 | 143.05M |
| 109 | COAG | Hemab Therapeutics Holdings, Inc. | 2.02B | 9.62% | 319,539 | - |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | -2.05% | 932,742 | 899.11M |
| 111 | KARD | Kardigan, Inc. | 1.99B | -5.40% | 275,696 | - |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.98B | 2.14% | 402,446 | 20.00M |
| 113 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | 6.73% | 1,122,824 | 42.95M |
| 114 | TYRA | Tyra Biosciences, Inc. | 1.96B | 0.64% | 564,775 | - |
| 115 | LKFT | Lakefront Biotherapeutics NV | 1.94B | -1.11% | 165,287 | 1.20B |
| 116 | SION | Sionna Therapeutics, Inc. | 1.92B | -3.09% | 273,600 | - |
| 117 | URGN | UroGen Pharma Ltd. | 1.91B | -0.81% | 551,310 | 140.49M |
| 118 | DMRA | Damora Therapeutics, Inc. | 1.91B | 10.68% | 519,828 | - |
| 119 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -4.57% | 2,930,689 | 2.18B |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.86B | 2.15% | 3,995,666 | 66.09M |
| 121 | ANAB | AnaptysBio, Inc. | 1.85B | -10.46% | 617,897 | 232.39M |
| 122 | BCAX | Bicara Therapeutics Inc. | 1.85B | -0.18% | 326,877 | - |
| 123 | GHRS | GH Research PLC | 1.84B | 5.60% | 93,805 | - |
| 124 | PGEN | Precigen, Inc. | 1.83B | -0.97% | 2,887,818 | 31.60M |
| 125 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 5.95% | 3,899,078 | 7.47M |
| 126 | GENB | Generate Biomedicines, Inc. | 1.82B | -0.49% | 382,939 | 30.30M |
| 127 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.23% | 684,298 | 10.00M |
| 128 | STOK | Stoke Therapeutics, Inc. | 1.81B | -1.12% | 551,116 | 32.08M |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | 1.21% | 24,694,238 | 66.41M |
| 130 | ZYME | Zymeworks Inc. | 1.77B | -1.12% | 340,356 | 81.26M |
| 131 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | -2.72% | 13,108,435 | 285.61M |
| 132 | ABSI | Absci Corporation | 1.73B | 0.20% | 3,252,938 | 1.84M |
| 133 | AAPG | Ascentage Pharma Group International | 1.73B | -1.84% | 3,048 | 82.08M |
| 134 | MPLT | MapLight Therapeutics, Inc. | 1.72B | 3.66% | 269,490 | - |
| 135 | FTRE | Fortrea Holdings Inc. | 1.71B | 0.95% | 725,941 | 2.71B |
| 136 | IMCR | Immunocore Holdings plc | 1.70B | 3.02% | 976,795 | 412.81M |
| 137 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.68B | 2.36% | 6,348,539 | 204.73M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.65B | 2.40% | 406,305 | 20.00M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.61B | -4.36% | 1,075,888 | - |
| 140 | INVA | Innoviva, Inc. | 1.60B | -2.12% | 805,540 | 420.69M |
| 141 | VIR | Vir Biotechnology, Inc. | 1.60B | -2.37% | 1,640,977 | 65.50M |
| 142 | SEPN | Septerna, Inc. | 1.56B | 0.52% | 588,311 | 72.26M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.52B | -3.27% | 288,404 | - |
| 144 | SVRA | Savara Inc. | 1.44B | -0.87% | 1,829,603 | - |
| 145 | AKTS | Aktis Oncology, Inc. | 1.39B | -1.58% | 745,999 | 8.28M |
| 146 | NVAX | Novavax, Inc. | 1.38B | -5.50% | 3,769,803 | 596.34M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 1.13% | 352,332 | 1.30M |
| 148 | IMTX | Immatics N.V. | 1.28B | 1.30% | 193,396 | 43.00M |
| 149 | ARDX | Ardelyx, Inc. | 1.27B | 0.39% | 2,639,459 | 427.68M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.19% | 1,166,546 | - |
| 151 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 1.77% | 1,416,844 | - |
| 152 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.58% | 201,465 | - |
| 153 | TRAX | First Tracks Biotherapeutics, Inc. | 1.20B | -1.83% | 692,481 | - |
| 154 | MNKD | MannKind Corporation | 1.20B | -3.96% | 4,606,609 | 360.78M |
| 155 | CAPR | Capricor Therapeutics, Inc. | 1.20B | 0.34% | 993,875 | 11.13M |
| 156 | WVE | Wave Life Sciences Ltd. | 1.18B | 3.03% | 2,051,745 | 71.80M |
| 157 | MGTX | MeiraGTx Holdings plc | 1.15B | 0.81% | 1,271,411 | 79.76M |
| 158 | EYPT | EyePoint, Inc. | 1.15B | -3.85% | 1,039,863 | 7.61M |
| 159 | DRTS | Alpha Tau Medical Ltd. | 1.11B | 1.31% | 384,140 | - |
| 160 | XNCR | Xencor, Inc. | 1.11B | -0.07% | 575,020 | 97.36M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 1.69% | 100,650 | - |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 0.86% | 942,010 | - |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -0.56% | 633,521 | - |
| 164 | SANA | Sana Biotechnology, Inc. | 1.07B | -1.92% | 1,988,842 | - |
| 165 | FBRX | Forte Biosciences, Inc. | 1.06B | -2.09% | 673,359 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | - | 786,090 | - |
| 167 | IVA | Inventiva S.A. | 1.03B | 2.33% | 1,276,345 | 7.94M |
| 168 | VOR | Vor Biopharma Inc. | 1.00B | 2.61% | 896,192 | - |
| 169 | KURA | Kura Oncology, Inc. | 997.82M | 3.02% | 1,570,560 | 71.64M |
| 170 | ANRO | Alto Neuroscience, Inc. | 975.61M | -0.82% | 559,916 | - |
| 171 | AVTX | Avalo Therapeutics, Inc. | 968.26M | -2.59% | 835,800 | 59.00K |
| 172 | JANX | Janux Therapeutics, Inc. | 962.33M | -2.23% | 830,291 | 13.73M |
| 173 | DBVT | DBV Technologies S.A. | 959.63M | -0.38% | 243,026 | 5.74M |
| 174 | SLDB | Solid Biosciences Inc. | 948.07M | -0.93% | 895,416 | - |
| 175 | PHAR | Pharming Group N.V. | 942.72M | -2.58% | 4,138 | 369.49M |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 941.70M | -2.30% | 1,518,482 | 69.64M |
| 177 | LBRX | LB Pharmaceuticals Inc | 918.23M | -0.71% | 209,258 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 910.65M | -1.18% | 1,670,329 | 191.45M |
| 179 | ANNX | Annexon, Inc. | 909.33M | -1.42% | 5,531,614 | - |
| 180 | GERN | Geron Corporation | 885.30M | -2.82% | 11,601,054 | 196.12M |
| 181 | TBPH | Theravance Biopharma, Inc. | 876.93M | 0.12% | 535,896 | 109.78M |
| 182 | PHAT | Phathom Pharmaceuticals, Inc. | 876.51M | 1.05% | 1,027,117 | 204.89M |
| 183 | FTH | Faeth Therapeutics, Inc. | 853.79M | -0.72% | 233,673 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 853.79M | -1.37% | 579,374 | - |
| 185 | ODTX | Odyssey Therapeutics, Inc. | 828.77M | -1.70% | 450,026 | 1.06M |
| 186 | REPL | Replimune Group, Inc. | 828.54M | -0.70% | 3,208,199 | - |
| 187 | CTMX | CytomX Therapeutics, Inc. | 796.79M | -1.08% | 4,592,190 | 35.54M |
| 188 | TENX | Tenax Therapeutics, Inc. | 794.99M | -2.63% | 1,221,814 | - |
| 189 | OCS | Oculis Holding AG | 780.82M | -1.67% | 305,832 | 1.40M |
| 190 | NGNE | Neurogene Inc. | 778.74M | 1.98% | 243,147 | 925.00K |
| 191 | AURA | Aura Biosciences, Inc. | 772.10M | - | 620,093 | - |
| 192 | ZVRA | Zevra Therapeutics, Inc. | 772.04M | -0.91% | 783,630 | 122.29M |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 761.73M | -0.31% | 270,803 | 299.77M |
| 194 | IMMX | Immix Biopharma, Inc. | 760.31M | 1.52% | 1,176,430 | - |
| 195 | OMER | Omeros Corporation | 759.94M | 4.90% | 1,354,416 | 9.89M |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 758.37M | -1.27% | 824,068 | 8.37M |
| 197 | CLYM | Climb Bio, Inc. | 758.13M | 0.23% | 813,535 | - |
| 198 | SPRY | ARS Pharmaceuticals, Inc. | 755.70M | -1.68% | 1,834,500 | 98.99M |
| 199 | DRUG | Bright Minds Biosciences Inc. | 743.89M | -2.50% | 242,798 | - |
| 200 | CADL | Candel Therapeutics, Inc. | 723.18M | 2.39% | 1,412,212 | - |
| 201 | XOMA | XOMA Royalty Corporation | 710.16M | - | - | 48.56M |
| 202 | SLBT | SL Science Holding Limited | 709.53M | 1.39% | 59,898 | - |
| 203 | GYRE | Gyre Therapeutics, Inc. | 706.84M | - | 78,543 | 117.05M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 706.54M | 3.52% | 418,054 | - |
| 205 | MNPR | Monopar Therapeutics Inc. | 668.47M | -3.43% | 488,839 | - |
| 206 | SGP | SpyGlass Pharma, Inc. | 668.33M | 0.45% | 162,411 | - |
| 207 | TECX | Tectonic Therapeutic, Inc. | 656.84M | 1.37% | 263,142 | - |
| 208 | RLMD | Relmada Therapeutics, Inc. | 651.37M | -3.72% | 959,532 | - |
| 209 | CRMD | CorMedix Inc. | 648.80M | -0.60% | 796,748 | 400.05M |
| 210 | ACHV | Achieve Life Sciences, Inc. | 647.78M | 3.44% | 1,617,336 | - |
| 211 | ALLO | Allogene Therapeutics, Inc. | 638.54M | -4.15% | 5,342,280 | 22.00K |
| 212 | RGNX | REGENXBIO Inc. | 635.38M | -3.61% | 1,560,090 | 87.82M |
| 213 | PRME | Prime Medicine, Inc. | 626.74M | -1.28% | 3,485,555 | 4.03M |
| 214 | MDXG | MiMedx Group, Inc. | 625.57M | 2.94% | 1,405,319 | 389.42M |
| 215 | FDMT | 4D Molecular Therapeutics, Inc. | 611.63M | 3.54% | 636,952 | 88.24M |
| 216 | AGMB | AgomAb Therapeutics NV | 592.95M | -2.19% | 48,063 | - |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 590.53M | -0.11% | 703,171 | 151.40M |
| 218 | NVCT | Nuvectis Pharma, Inc. | 576.60M | -0.81% | 99,409 | - |
| 219 | ALT | Altimmune, Inc. | 569.81M | -2.01% | 3,247,927 | 36.00K |
| 220 | EIKN | Eikon Therapeutics, Inc. | 551.67M | -2.39% | 269,461 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 544.72M | -0.34% | 252,237 | - |
| 222 | ARVN | Arvinas, Inc. | 533.59M | 2.10% | 622,029 | 89.40M |
| 223 | ASMB | Assembly Biosciences, Inc. | 530.31M | -0.74% | 103,385 | 71.10M |
| 224 | CBIO | Crescent Biopharma, Inc. | 508.57M | -2.45% | 76,916 | 11.88M |
| 225 | RZLT | Rezolute, Inc. | 504.57M | 1.90% | 1,501,494 | - |
| 226 | VSTM | Verastem, Inc. | 489.46M | 3.72% | 2,956,753 | 49.59M |
| 227 | EDIT | Editas Medicine, Inc. | 484.94M | - | 1,816,150 | 38.69M |
| 228 | OCGN | Ocugen, Inc. | 484.09M | 1.42% | 4,932,152 | 4.47M |
| 229 | KYTX | Kyverna Therapeutics, Inc. | 482.71M | 2.19% | 1,306,134 | - |
| 230 | STTK | Shattuck Labs, Inc. | 482.32M | -2.18% | 738,258 | 1.00M |
| 231 | ZURA | Zura Bio Limited | 480.69M | -1.75% | 780,509 | - |
| 232 | SGMT | Sagimet Biosciences Inc. | 478.89M | 8.46% | 1,158,556 | - |
| 233 | VALN | Valneva SE | 478.73M | -2.85% | 56,743 | 180.25M |
| 234 | PROK | ProKidney Corp. | 468.19M | -3.73% | 1,770,211 | 889.00K |
| 235 | SLN | Silence Therapeutics plc | 460.53M | 4.95% | 333,280 | 839.00K |
| 236 | OVID | Ovid Therapeutics Inc. | 459.13M | 1.23% | 1,225,605 | 7.12M |
| 237 | ARTV | Artiva Biotherapeutics, Inc. | 454.30M | 4.70% | 415,557 | 251.00K |
| 238 | PRTA | Prothena Corporation plc | 452.33M | -2.15% | 522,031 | 57.94M |
| 239 | BNTC | Benitec Biopharma Inc. | 445.92M | -0.08% | 65,169 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 435.39M | -1.13% | 322,446 | 16.72M |
| 241 | CABA | Cabaletta Bio, Inc. | 435.36M | -3.44% | 3,134,870 | - |
| 242 | EVMN | Evommune, Inc. | 431.86M | -0.91% | 572,883 | 10.00M |
| 243 | STRO | Sutro Biopharma, Inc. | 431.33M | -6.50% | 217,687 | 99.61M |
| 244 | PBYI | Puma Biotechnology, Inc. | 421.45M | 2.48% | 423,686 | 227.18M |
| 245 | CCCC | C4 Therapeutics, Inc. | 421.26M | -2.81% | 3,031,525 | 34.86M |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 414.12M | -1.40% | 184,766 | - |
| 247 | HELP | Cybin Inc. | 414.05M | -0.30% | 701,716 | - |
| 248 | ABEO | Abeona Therapeutics Inc. | 402.39M | 0.71% | 1,074,895 | 14.54M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 400.35M | -0.80% | 147,980 | - |
| 250 | RCKT | Rocket Pharmaceuticals, Inc. | 397.46M | -2.15% | 1,067,591 | - |
| 251 | VTVT | vTv Therapeutics Inc. | 395.62M | 0.95% | 57,880 | 36.84M |
| 252 | CMPX | Compass Therapeutics, Inc. | 394.39M | -3.10% | 1,997,575 | 850.00K |
| 253 | UPB | Upstream Bio, Inc. | 388.56M | -1.92% | 340,034 | 3.32M |
| 254 | LRMR | Larimar Therapeutics, Inc. | 388.30M | -0.13% | 1,809,819 | - |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 387.67M | 3.81% | 163,983 | 51.00M |
| 256 | AUTL | Autolus Therapeutics plc | 385.91M | -2.03% | 2,973,715 | 92.62M |
| 257 | IPSC | Century Therapeutics, Inc. | 384.16M | -3.18% | 1,613,628 | 109.16M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 381.22M | -3.89% | 136,393 | 69.21M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 379.17M | -0.74% | 1,131,873 | 9.01M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 376.13M | -0.84% | 337,368 | - |
| 261 | ANL | Adlai Nortye Ltd. | 368.00M | -0.43% | 216,799 | 5.00M |
| 262 | LXEO | Lexeo Therapeutics, Inc. | 362.77M | -0.54% | 600,833 | - |
| 263 | VNDA | Vanda Pharmaceuticals Inc. | 351.79M | -2.50% | 1,052,095 | 217.78M |
| 264 | GALT | Galectin Therapeutics Inc. | 351.68M | 16.09% | 2,071,213 | - |
| 265 | IKT | Inhibikase Therapeutics, Inc. | 351.07M | 5.10% | 4,020,328 | 1.00 |
| 266 | FATE | Fate Therapeutics, Inc. | 348.51M | -0.99% | 1,853,532 | 6.32M |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 343.65M | -2.06% | 11,258 | 370.61K |
| 268 | ZNTL | Zentalis Pharmaceuticals, Inc. | 339.56M | 3.25% | 844,685 | 26.87M |
| 269 | IMRX | Immuneering Corporation | 337.07M | 0.97% | 551,595 | - |
| 270 | PALI | Palisade Bio, Inc. | 335.01M | 2.12% | 3,294,889 | - |
| 271 | FHTX | Foghorn Therapeutics Inc. | 315.88M | -1.10% | 229,036 | 28.22M |
| 272 | ELDN | Eledon Pharmaceuticals, Inc. | 313.07M | 4.92% | 1,019,694 | - |
| 273 | QTTB | Q32 Bio Inc. | 313.02M | -13.66% | 3,541,026 | 53.74M |
| 274 | LYEL | Lyell Immunopharma, Inc. | 312.68M | -6.49% | 168,524 | 31.00K |
| 275 | OABI | OmniAb, Inc. | 310.24M | 1.42% | 543,071 | 28.94M |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 304.14M | 0.83% | 771,333 | 14.78M |
| 277 | INDP | Indaptus Therapeutics, Inc. | 297.83M | - | 23,777 | - |
| 278 | IFRX | InflaRx N.V. | 296.06M | -2.43% | 1,548,188 | 33.82K |
| 279 | IRD | Opus Genetics, Inc. | 293.93M | -6.56% | 953,945 | 11.98M |
| 280 | BCYC | Bicycle Therapeutics plc | 293.91M | -3.22% | 282,485 | 63.50M |
| 281 | NMRA | Neumora Therapeutics, Inc. | 292.75M | -1.25% | 766,961 | - |
| 282 | TTRX | Turn Therapeutics Inc. | 287.16M | 1.80% | 66,499 | - |
| 283 | GLSI | Greenwich LifeSciences, Inc. | 279.03M | 2.37% | 87,708 | - |
| 284 | SABS | SAB Biotherapeutics, Inc. | 275.27M | -3.49% | 316,657 | 114.70K |
| 285 | MGNX | MacroGenics, Inc. | 272.69M | -4.67% | 1,245,423 | 157.08M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 269.13M | 1.52% | 762,401 | - |
| 287 | NAGE | Niagen Bioscience, Inc. | 262.58M | -5.19% | 858,379 | 130.42M |
| 288 | CNXU | Conexeu Sciences Inc. | 254.20M | -8.12% | 150,245 | - |
| 289 | SRZN | Surrozen, Inc. | 254.03M | -4.08% | 222,697 | 7.49M |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 253.27M | -0.12% | 112,037 | 1.78M |
| 291 | SLGL | Sol-Gel Technologies Ltd. | 246.45M | 2.00% | 16,746 | 18.47M |
| 292 | TRDA | Entrada Therapeutics, Inc. | 245.03M | 3.03% | 237,682 | 5.74M |
| 293 | PRQR | ProQR Therapeutics N.V. | 239.91M | - | 990,543 | 15.73M |
| 294 | FULC | Fulcrum Therapeutics, Inc. | 239.21M | 1.41% | 1,287,187 | 80.00M |
| 295 | ACIU | AC Immune SA | 239.07M | -1.63% | 162,523 | 4.62M |
| 296 | ADAG | Adagene Inc. | 238.52M | -5.50% | 225,422 | 7.67M |
| 297 | IVVD | Invivyd, Inc. | 235.92M | 1.69% | 1,669,680 | 55.87M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 231.07M | -1.11% | 163,415 | 3.93M |
| 299 | TARA | Protara Therapeutics, Inc. | 229.88M | -2.15% | 411,439 | - |
| 300 | KPTI | Karyopharm Therapeutics Inc. | 226.86M | -0.40% | 467,604 | 151.12M |
| 301 | AVXL | Anavex Life Sciences Corp. | 225.19M | 3.40% | 860,729 | - |
| 302 | CHRS | Coherus Oncology, Inc. | 223.66M | -1.36% | 417,174 | 46.88M |
| 303 | NAUT | Nautilus Biotechnology, Inc. | 222.39M | -1.69% | 534,067 | - |
| 304 | DTIL | Precision BioSciences, Inc. | 221.38M | -0.12% | 315,403 | 45.07M |
| 305 | OBIO | Orchestra BioMed Holdings, Inc. | 220.96M | -3.40% | 352,966 | 32.72M |
| 306 | CGEN | Compugen Ltd. | 217.54M | - | 137,576 | 72.66M |
| 307 | AGEN | Agenus Inc. | 211.54M | -16.99% | 11,001,530 | 123.87M |
| 308 | CLLS | Cellectis S.A. | 211.02M | -0.86% | 15,285 | 75.11M |
| 309 | KROS | Keros Therapeutics, Inc. | 209.20M | -4.77% | 154,947 | 33.18M |
| 310 | OTLK | Outlook Therapeutics, Inc. | 209.09M | 11.61% | 16,278,772 | 333.14K |
| 311 | RNA | Atrium Therapeutics, Inc. | 209.03M | - | 205,793 | 36.68M |
| 312 | NBP | NovaBridge Biosciences | 208.17M | -3.23% | 353,542 | - |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 204.91M | -0.78% | 288,570 | 7.15M |
| 314 | IMUX | Immunic, Inc. | 200.10M | 0.34% | 167,170 | - |
| 315 | CDXS | Codexis, Inc. | 193.61M | -5.33% | 922,266 | 78.09M |
| 316 | KRRO | Korro Bio, Inc. | 191.39M | -1.70% | 199,291 | 3.84M |
| 317 | VYGR | Voyager Therapeutics, Inc. | 190.93M | -2.47% | 878,397 | 36.49M |
| 318 | HUMA | Humacyte, Inc. | 190.69M | 2.31% | 7,443,761 | 2.02M |
| 319 | NKTX | Nkarta, Inc. | 189.60M | -5.02% | 788,151 | - |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 187.62M | 3.36% | 1,780,018 | 225.00K |
| 321 | NERV | Minerva Neurosciences, Inc. | 187.29M | -5.85% | 166,536 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 186.12M | -3.35% | 813,461 | 76.38M |
| 323 | NGEN | NervGen Pharma Corp. | 184.79M | -9.84% | 1,299,741 | - |
| 324 | MDWD | MediWound Ltd. | 183.14M | - | 82,001 | 14.48M |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 182.74M | -4.17% | 533,646 | - |
| 326 | CBUS | Cibus, Inc. | 182.43M | 12.21% | 1,601,598 | 4.29M |
| 327 | NRXP | NRx Pharmaceuticals, Inc. | 181.47M | 4.34% | 1,367,104 | 2.29M |
| 328 | ARCT | Arcturus Therapeutics Holdings Inc. | 181.05M | -5.07% | 637,496 | 54.71M |
| 329 | CNTN | Canton Strategic Holdings, Inc. | 177.38M | 1.32% | 704,071 | - |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 176.87M | 1.56% | 864,058 | 1.78M |
| 331 | TNXP | Tonix Pharmaceuticals Holding Corp. | 176.31M | -5.55% | 607,169 | 17.56M |
| 332 | ACOG | Alpha Cognition Inc. | 175.28M | -3.94% | 131,256 | 10.83M |
| 333 | EQ | Equillium, Inc. | 174.51M | -4.17% | 271,141 | 4.39M |
| 334 | CRBU | Caribou Biosciences, Inc. | 173.57M | -2.78% | 3,923,026 | 11.20M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 171.44M | 4.62% | 352,432 | - |
| 336 | OKUR | OnKure Therapeutics, Inc. | 170.47M | 2.68% | 87,483 | - |
| 337 | IPHA | Innate Pharma S.A. | 170.29M | - | 4,901 | 10.57M |
| 338 | PEPG | PepGen Inc. | 168.77M | - | 2,069,868 | - |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 167.31M | -0.11% | 322,384 | - |
| 340 | MENS | Jyong Biotech Ltd. | 164.80M | 0.45% | 40,930 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 163.70M | 1.14% | 140,061 | 2.00M |
| 342 | TLSA | Tiziana Life Sciences Ltd | 160.34M | -6.77% | 537,084 | - |
| 343 | LENZ | LENZ Therapeutics, Inc. | 154.58M | -5.74% | 1,621,067 | 20.99M |
| 344 | ALEC | Alector, Inc. | 154.33M | -7.95% | 517,261 | 18.42M |
| 345 | KZIA | Kazia Therapeutics Limited | 153.92M | -0.88% | 186,580 | 1.27M |
| 346 | HURA | TuHURA Biosciences, Inc. | 151.56M | - | 551,703 | - |
| 347 | YDES | YD Bio Limited | 149.08M | -1.40% | 60,996 | 510.36K |
| 348 | CNTB | Connect Biopharma Holdings Limited | 148.28M | 4.20% | 1,107,294 | 233.00K |
| 349 | MOLN | Molecular Partners AG | 146.73M | -0.25% | 881 | 856.30K |
| 350 | PYXS | Pyxis Oncology, Inc. | 145.08M | -6.15% | 1,042,318 | 13.86M |
| 351 | ARMP | Armata Pharmaceuticals, Inc. | 143.91M | -1.26% | 149,037 | 5.20M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 139.37M | 2.55% | 574,564 | - |
| 353 | AARD | Aardvark Therapeutics, Inc. | 136.57M | 5.03% | 335,840 | - |
| 354 | CUE | Cue Biopharma, Inc. | 131.39M | 1.16% | 160,200 | 32.73M |
| 355 | GNLX | Genelux Corporation | 128.34M | -2.36% | 174,142 | 8.00K |
| 356 | SPRB | Spruce Biosciences, Inc. | 127.60M | -4.18% | 88,442 | 697.00K |
| 357 | ENGN | enGene Therapeutics Inc. | 126.95M | 1.88% | 1,311,986 | - |
| 358 | GUTS | Fractyl Health, Inc. | 126.92M | 5.03% | 1,339,553 | 3.00K |
| 359 | FBIO | Fortress Biotech, Inc. | 123.91M | 13.03% | 1,209,652 | 66.16M |
| 360 | PMN | ProMIS Neurosciences, Inc. | 122.50M | 6.72% | 131,908 | - |
| 361 | VANI | Vivani Medical, Inc. | 120.73M | -1.41% | 224,499 | - |
| 362 | SEER | Seer, Inc. | 118.76M | -0.46% | 138,658 | 15.17M |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 116.42M | - | 817,447 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 114.24M | 0.31% | 440,446 | 7.94M |
| 365 | ANIX | Anixa Biosciences, Inc. | 108.53M | 4.25% | 185,354 | - |
| 366 | ONCY | Oncolytics Biotech Inc. | 108.40M | -2.23% | 1,840,812 | - |
| 367 | KLRS | Kalaris Therapeutics, Inc. | 108.25M | 2.94% | 35,402 | - |
| 368 | PLYX | Polaryx Therapeutics, Inc. | 107.00M | 2.73% | 64,435 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 106.58M | -2.11% | 606,119 | 70.00M |
| 370 | ICCC | ImmuCell Corporation | 106.03M | 5.78% | 46,545 | 29.93M |
| 371 | PYPD | PolyPid Ltd. | 102.58M | 6.15% | 213,712 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 101.87M | 0.17% | 10,657 | 37.16M |
| 373 | SPRO | Spero Therapeutics, Inc. | 98.43M | -22.02% | 10,753,182 | 61.19M |
| 374 | ENLV | Enlivex Ltd. | 97.22M | -9.30% | 51,619 | - |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 95.44M | - | 962,397 | 65.34K |
| 376 | NTHI | NeOnc Technologies Holdings, Inc. | 95.43M | -14.81% | 168,983 | 39.99K |
| 377 | BMEA | Biomea Fusion, Inc. | 93.27M | -3.01% | 717,322 | - |
| 378 | ACET | Adicet Bio, Inc. | 92.72M | 3.27% | 115,517 | - |
| 379 | ATHE | Alterity Therapeutics Limited | 91.20M | -6.51% | 22,326 | 4.43M |
| 380 | ACRV | Acrivon Therapeutics, Inc. | 91.17M | 7.58% | 1,000,167 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 90.39M | -0.98% | 1,277,445 | - |
| 382 | CRDF | Cardiff Oncology, Inc. | 89.56M | -2.96% | 659,559 | 525.00K |
| 383 | LONA | LeonaBio, Inc. | 89.43M | -2.46% | 13,264 | - |
| 384 | NRXS | NeurAxis, Inc. | 88.55M | 3.92% | 113,414 | 4.28M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 88.28M | -3.24% | 50,104 | 27.70M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 87.55M | 1.41% | 1,463,940 | - |
| 387 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | - | 49,977 | - |
| 388 | RNTX | Rein Therapeutics Inc. | 85.21M | 0.91% | 362,308 | - |
| 389 | RLYB | Rallybio Corporation | 84.82M | 0.76% | 137,558 | 858.00K |
| 390 | OKYO | OKYO Pharma Limited | 82.92M | 1.94% | 35,162 | - |
| 391 | HRTX | Heron Therapeutics, Inc. | 81.37M | 3.12% | 3,463,644 | 150.71M |
| 392 | RANI | Rani Therapeutics Holdings, Inc. | 80.40M | 2.59% | 454,772 | 3.17M |
| 393 | ENTX | Entera Bio Ltd. | 79.85M | -1.22% | 151,065 | 42.00K |
| 394 | ALPS | Alps Group Inc | 79.44M | -4.73% | 257,338 | 3.74M |
| 395 | CSBR | Champions Oncology, Inc. | 78.60M | -2.58% | 31,472 | 57.95M |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 75.73M | 10.94% | 1,104,989 | - |
| 397 | OSTX | OS Therapies Incorporated | 73.93M | 2.47% | 450,535 | - |
| 398 | HYFT | MindWalk Holdings Corp. | 73.51M | 4.96% | 193,464 | 20.70M |
| 399 | ANVS | Annovis Bio, Inc. | 72.75M | -2.84% | 1,591,488 | - |
| 400 | ATRA | Atara Biotherapeutics, Inc. | 72.44M | -7.27% | 201,191 | 23.14M |
| 401 | GANX | Gain Therapeutics, Inc. | 71.66M | -4.55% | 1,466,384 | - |
| 402 | IBIO | iBio, Inc. | 71.54M | -0.69% | 1,087,706 | 300.00K |
| 403 | XBIT | XBiotech Inc. | 69.82M | -1.72% | 26,288 | - |
| 404 | GOSS | Gossamer Bio, Inc. | 68.49M | -2.78% | 41,245,651 | 55.54M |
| 405 | IMA | ImageneBio, Inc. | 67.90M | -1.47% | 3,790 | 800.00K |
| 406 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 14,896 | 596.64K |
| 407 | PLRX | Pliant Therapeutics, Inc. | 66.98M | -4.39% | 2,581,456 | - |
| 408 | CING | Cingulate Inc. | 63.44M | 0.64% | 197,497 | - |
| 409 | TCRX | TScan Therapeutics, Inc. | 60.78M | -9.71% | 1,610,275 | 9.14M |
| 410 | EDSA | Edesa Biotech, Inc. | 59.93M | -1.03% | 69,214 | - |
| 411 | EXOZ | eXoZymes, Inc. | 59.35M | 9.89% | 2,671 | -700.00 |
| 412 | ELTX | Elicio Therapeutics, Inc. | 59.31M | -5.47% | 778,683 | - |
| 413 | CNTX | Context Therapeutics Inc. | 57.23M | -0.14% | 1,730,842 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 56.84M | 2.33% | 11,020 | - |
| 415 | IMMP | Immutep Limited | 56.64M | -3.93% | 317,266 | 5.28M |
| 416 | BOLD | Boundless Bio, Inc. | 55.26M | 0.82% | 304,971 | - |
| 417 | BYSI | BeyondSpring Inc. | 54.69M | - | 19,424 | 1.88M |
| 418 | XLO | Xilio Therapeutics, Inc. | 54.03M | -2.27% | 100,731 | 53.48M |
| 419 | INMB | INmune Bio Inc. | 53.70M | 8.60% | 1,012,535 | 50.00K |
| 420 | TIL | Instil Bio, Inc. | 53.00M | 2.29% | 18,185 | - |
| 421 | VRXA | Veraxa Biotech AG | 52.70M | -2.34% | 361,540 | - |
| 422 | FLNA | Filana Therapeutics, Inc. | 52.66M | -5.22% | 526,721 | - |
| 423 | IBO | Impact BioMedical Inc. | 51.75M | 3.67% | 57,925 | 39.00K |
| 424 | MCRB | Seres Therapeutics, Inc. | 51.66M | -5.07% | 220,152 | 1.15M |
| 425 | MREO | Mereo BioPharma Group plc | 50.12M | -2.18% | 552,464 | 500.00K |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 49.69M | - | 218,271 | 22.33M |
| 427 | RADX | Radiopharm Theranostics Limited | 49.53M | -0.69% | 28,649 | 10.86M |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 48.09M | 3.62% | 46,536 | - |
| 429 | ATYR | aTyr Pharma, Inc. | 47.65M | -3.59% | 930,420 | 190.00K |
| 430 | ELOX | Eloxx Pharmaceuticals, Inc. | 45.45M | -0.79% | 10,327 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 44.87M | -0.34% | 132,110 | 1.04M |
| 432 | DYAI | Dyadic International, Inc. | 44.09M | 18.63% | 761,827 | 3.81M |
| 433 | PDSB | PDS Biotechnology Corporation | 41.97M | 0.91% | 442,036 | - |
| 434 | CRVO | CervoMed Inc. | 41.66M | -6.95% | 887,448 | 2.09M |
| 435 | ACTU | Actuate Therapeutics, Inc. | 41.39M | 15.33% | 2,686,880 | - |
| 436 | NNVC | NanoViricides, Inc. | 40.32M | 7.27% | 680,107 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 40.03M | 1.23% | 151,015 | - |
| 438 | LTRN | Lantern Pharma Inc. | 39.17M | -11.27% | 137,689 | - |
| 439 | RNXT | RenovoRx, Inc. | 38.33M | -6.94% | 398,467 | 1.49M |
| 440 | ALGS | Aligos Therapeutics, Inc. | 37.78M | -4.01% | 99,393 | 4.71M |
| 441 | VERU | Veru Inc. | 37.08M | -9.77% | 466,272 | 16.89M |
| 442 | NTRB | Nutriband Inc. | 36.22M | 1.36% | 8,755 | 1.80M |
| 443 | ESLA | Estrella Immunopharma, Inc. | 35.12M | -6.81% | 40,956 | - |
| 444 | APLM | Apollomics, Inc. | 34.48M | 10.49% | 154,688 | 8.84M |
| 445 | LITS | Lite Strategy, Inc. | 33.92M | 5.40% | 116,788 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 33.86M | -0.74% | 57,880 | 797.92K |
| 447 | LSTA | Lisata Therapeutics, Inc. | 33.78M | 0.27% | 20,574 | 170.00K |
| 448 | BCTX | BriaCell Therapeutics Corp. | 32.31M | -1.33% | 192,871 | - |
| 449 | SER | Serina Therapeutics, Inc. | 31.34M | 1.95% | 29,494 | 130.00K |
| 450 | DARE | Daré Bioscience, Inc. | 31.01M | -0.96% | 56,116 | 1.16M |
| 451 | SNTI | Senti Biosciences Holdings, Inc. | 30.13M | 0.78% | 58,859 | 38.00K |
| 452 | KYNB | Kyntra Bio, Inc. | 29.63M | -0.41% | 11,076 | 7.44M |
| 453 | GNTA | Genenta Science S.p.A. | 29.49M | -5.30% | 70,178 | - |
| 454 | PSTV | Plus Therapeutics, Inc. | 29.46M | 2.64% | 366,635 | 5.18M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 29.08M | -6.34% | 1,650,611 | - |
| 456 | ATNM | Actinium Pharmaceuticals, Inc. | 28.08M | -1.09% | 123,131 | 90.00K |
| 457 | IGC | IGC Pharma, Inc. | 26.72M | 0.41% | 399,676 | 1.11M |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 25.81M | - | 24,567 | - |
| 459 | PLRZ | Polyrizon Ltd. | 25.75M | -0.76% | 111,184 | - |
| 460 | GRDX | GridAI Technologies Corp. | 25.55M | -5.65% | 61,024 | - |
| 461 | EVAX | Evaxion A/S | 25.27M | 0.33% | 20,962 | 7.53M |
| 462 | BRNS | Barinthus Biotherapeutics plc | 25.01M | 0.36% | 27,047 | 14.97M |
| 463 | MRKR | Marker Therapeutics, Inc. | 24.01M | -1.37% | 21,375 | 3.55M |
| 464 | NXTC | NextCure, Inc. | 23.77M | 201.83% | 110,469,836 | - |
| 465 | VYNE | VYNE Therapeutics Inc. | 23.71M | 8.07% | 1,430,447 | 454.00K |
| 466 | AKTX | Akari Therapeutics, Plc | 23.49M | 0.15% | 40,512 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 21.94M | -1.13% | 45,721 | - |
| 468 | CELU | Celularity Inc. | 21.85M | -0.01% | 49,426 | 26.55M |
| 469 | SKYE | Skye Bioscience, Inc. | 21.79M | -6.33% | 389,346 | - |
| 470 | NCEL | NewcelX Ltd. | 21.43M | -0.50% | 27,826 | - |
| 471 | TVGN | Tevogen Bio Holdings Inc. | 21.02M | 0.40% | 9,031 | - |
| 472 | CLRB | Cellectar Biosciences, Inc. | 21.02M | - | 43,701 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 20.24M | 18.90% | 3,111,622 | - |
| 474 | CVM | CEL-SCI Corporation | 20.10M | -5.74% | 321,733 | - |
| 475 | LGVN | Longeveron Inc. | 19.66M | -1.38% | 181,193 | 1.22M |
| 476 | ATOS | Atossa Therapeutics, Inc. | 19.46M | -5.83% | 154,440 | - |
| 477 | ICU | SeaStar Medical Holding Corporation | 19.30M | 0.21% | 66,113 | 1.44M |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 19.29M | 2.29% | 35,806 | -13.27K |
| 479 | LPCN | Lipocine Inc. | 19.04M | -1.70% | 26,110 | 2.00M |
| 480 | QNCX | Quince Therapeutics, Inc. | 18.86M | 11.83% | 83,410 | - |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.46M | 2.65% | 97,140 | 345.00K |
| 482 | PLUR | Pluri Inc. | 18.13M | 3.07% | 72,441 | 1.08M |
| 483 | KALA | KALA BIO, Inc. | 17.91M | -11.62% | 229,993 | - |
| 484 | HOWL | Werewolf Therapeutics, Inc. | 16.72M | 0.76% | 1,291,137 | 1.14M |
| 485 | PTN | Palatin Technologies, Inc. | 16.28M | -7.04% | 17,708 | 12.88M |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 16.24M | 0.26% | 30,462 | 1.99M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 16.10M | -1.65% | 158,896 | - |
| 488 | MLEC | Moolec Science SA | 15.56M | 0.81% | 4,728 | 7.83M |
| 489 | HIND | Vyome Holdings, Inc. | 15.30M | -2.68% | 10,735 | 152.72K |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 14.60M | -1.48% | 178,456 | 5.61M |
| 491 | LEXX | Lexaria Bioscience Corp. | 14.56M | -1.29% | 50,607 | 194.00K |
| 492 | TPST | Tempest Therapeutics, Inc. | 14.52M | -0.31% | 171,721 | - |
| 493 | PASG | Passage Bio, Inc. | 14.24M | -0.45% | 58,570 | - |
| 494 | INAB | IN8bio, Inc. | 13.59M | 2.99% | 16,112 | - |
| 495 | LNAI | Lunai Bioworks Inc. | 13.51M | 5.30% | 32,211 | 20.94K |
| 496 | GTBP | GT Biopharma, Inc. | 13.31M | -4.82% | 1,953,347 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 13.16M | -1.02% | 53,108 | - |
| 498 | BLRX | BioLineRx Ltd. | 13.12M | -4.29% | 8,723 | 1.40M |
| 499 | COCP | Cocrystal Pharma, Inc. | 12.96M | -2.05% | 61,203 | 225.00K |
| 500 | OSRH | OSR Health, Inc. | 12.71M | 1.71% | 403,864 | 2.63M |